No Association Between Pharmacogenomics Variants and Hospital and Emergency Department Utilization: A Mayo Clinic Biobank Retrospective Study
Paul Y Takahashi,1 Euijung Ryu,2 Suzette J Bielinski,3 Matthew Hathcock,2 Gregory D Jenkins,2 James R Cerhan,3 Janet E Olson3 1Division of Community Internal Medicine, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA; 2Division of Biomedical Statistics and Informatics, Department of...
Saved in:
Main Authors: | Takahashi PY (Author), Ryu E (Author), Bielinski SJ (Author), Hathcock M (Author), Jenkins GD (Author), Cerhan JR (Author), Olson JE (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2021-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pathway to Ascertain the Role of Pharmacogenomics in Healthcare Utilization Outcomes [Response to Letter]
by: Takahashi PY, et al.
Published: (2021) -
Increased risk of hospitalization for ultrarapid metabolizers of cytochrome P450 2D6
by: Takahashi PY, et al.
Published: (2017) -
Characteristics Associated With Recruitment and Re-contact in Mayo Clinic Biobank
by: Matthew A. Hathcock, et al.
Published: (2020) -
Concepts Driving Pharmacogenomics Implementation Into Everyday Healthcare
by: Giri J, et al.
Published: (2019) -
Mini-Review of Laboratory Operations in Biobanking: Building Biobanking Resources for Translational Research
by: Mine S. Cicek, et al.
Published: (2020)